INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,568,223 | -73.5% | 28,024 | -75.5% | 0.01% | -73.5% |
| Q2 2022 | $5,921,499 | -47.3% | 114,403 | -26.1% | 0.05% | -31.0% |
| Q1 2022 | $11,245,392 | +5.5% | 154,746 | +71.7% | 0.07% | +14.5% |
| Q4 2021 | $10,656,025 | -28.9% | 90,122 | -19.3% | 0.06% | -43.6% |
| Q3 2021 | $14,990,055 | -30.8% | 111,741 | -16.4% | 0.11% | -19.1% |
| Q2 2021 | $21,647,367 | +122.1% | 133,700 | +10.1% | 0.14% | +58.1% |
| Q1 2021 | $9,747,211 | +646.6% | 121,453 | +406.1% | 0.09% | +681.8% |
| Q4 2020 | $1,305,600 | +406.0% | 24,000 | +84.6% | 0.01% | +266.7% |
| Q3 2020 | $258,000 | -64.2% | 13,000 | -73.6% | 0.00% | -50.0% |
| Q4 2019 | $721,000 | – | 49,175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |